Finance

Lists
OLY1:FRA
Olympus Corp
€11,19
+0,36%
(+0,040) 1D
30 Sep., 08:02:11 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for OLY1...
Open
€11,19
High
€11,19
Low
€11,19
Mkt. cap
2,25 bn
Avg. vol.
69,00
Volume
0,00
52-wk high
€11,74
52-wk low
€7,01
No. of employees
28 k
Open
€11,19
High
€11,19
Low
€11,19
Mkt. cap
2,25 bn
Avg. vol.
69,00
Volume
0,00
52-wk high
€11,74
52-wk low
€7,01
No. of employees
28 k
Profile
Olympus Corporation is a Japanese manufacturer of optics and reprography products, headquartered in Hachioji, Tokyo. Olympus was founded on October 12, 1919 as Takachiho Seisakusho by Takeshi Yamashita, initially specializing in microscopes and thermometers, and later in imaging. In 1921, the name Olympus was registered as a trademark. In 1942, the company was renamed Takachiho Optical Industries, and in 1949 it was renamed Olympus Optical Co., Ltd. In 2003, the company adopted its current name, Olympus Corporation. Olympus holds roughly a 70 percent share of the global endoscope market, estimated to be worth approximately US$2.5 billion. As of 2025, endoscopes and related surgical technologies are now Olympus's exclusive product line. It was formerly also a maker of cameras, camera lenses and dictaphones, until it divested this part to OM Digital Solutions in 2020. It divested from its microscopy and scientific imaging division in 2023, selling it to Bain Capital for approximately $3.1 billion; the division operates as Evident Corporation. Wikipedia
About Olympus Corp
CEOYasuo Takeuchi
Employees28,1 k
Founded12 Okt. 1919
Headquarters-
SectorMedical device
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
247,84 mjd
261,04 mjd
295,28 mjd
240,40 mjd
Cost of goods sold
86,54 mjd
96,15 mjd
102,52 mjd
83,57 mjd
Cost of revenue
86,54 mjd
96,15 mjd
102,52 mjd
83,57 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
119,90 mjd
125,65 mjd
104,14 mjd
125,03 mjd
Operating expense
127,74 mjd
140,86 mjd
145,88 mjd
126,76 mjd
Total operating expenses
214,27 mjd
237,01 mjd
248,41 mjd
210,33 mjd
Operating income
33,56 mjd
24,04 mjd
46,88 mjd
30,07 mjd
Other non operating income
-
-
-819,00 m
-
EBT including unusual items
27,90 mjd
22,13 mjd
27,08 mjd
27,56 mjd
EBT excluding unusual items
27,90 mjd
22,13 mjd
47,09 mjd
27,56 mjd
Income tax expense
7,70 mjd
7,96 mjd
2,26 mjd
8,46 mjd
Effective tax rate
27,61%
35,98%
8,36%
30,69%
Other operating expenses
7,83 mjd
15,21 mjd
6,54 mjd
1,72 mjd
Net income
20,20 mjd
14,17 mjd
24,82 mjd
19,10 mjd
Net profit margin
8,15%
5,43%
8,40%
7,95%
Earnings per share
-
-
-
-
Interest and investment income
3,64 mjd
356,00 m
3,96 mjd
1,43 mjd
Interest expense
-5,28 mjd
-2,34 mjd
-2,92 mjd
-2,82 mjd
Net interest expenses
-1,64 mjd
-1,99 mjd
1,04 mjd
-1,39 mjd
Depreciation and amortization charges
-
-
35,20 mjd
-
EBITDA
50,30 mjd
41,76 mjd
63,42 mjd
47,38 mjd
Gain or loss from assets sale
-
-
12,08 mjd
-
AI content may include mistakes. Learn more
Google-programme